Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo says it more than doubled R&D spending from 2020 to 2023, as the company ran large clinical trials and added experimental programs across more types of diseases. Novo is different from most ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

This Novo Nordisk business report presents the course of business throughout the respective business year 2020. The report complies with the disclosure requirement for corporate entities and ...

Novo Nordisk says Wegovy can help heart disease ... Its injectable counterpart, Ozempic, in 2020 won an FDA approval to reduce the risk of cardiovascular-related events in Type 2 diabetes patients ...

Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat versions of its popular weight ...